Suppr超能文献

微血管侵犯对单发小 HCC 术后长期预后的影响:系统评价和荟萃分析。

Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis.

机构信息

Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

Company 8 of Student Bridge, Second Military Medical University, Shanghai, China.

出版信息

HPB (Oxford). 2019 Aug;21(8):935-944. doi: 10.1016/j.hpb.2019.02.003. Epub 2019 Mar 11.

Abstract

BACKGROUND

The effect of microvascular invasion (MVI) on the postoperative long-term prognosis of solitary small hepatocellular carcinoma remains controversial. We compared the long-term outcomes of MVI-positive and MVI-negative groups of patients with solitary small hepatocellular carcinoma.

METHODS

The PubMed, EMBASE, Cochrane Library, VIP, Wan Fang, and Sino Med databases were systematically searched to compare the long-term outcomes of MVI-positive and MVI-negative groups of patients with solitary small hepatocellular carcinoma from inception to November 1, 2018. The study outcomes, including overall survival (OS) and disease-free survival (DFS), were extracted independently by two authors.

RESULTS

Fourteen studies involving 3033 patients were evaluated. A meta-analysis of all 14 studies suggested that the OS of the MVI-positive group was significantly worse than that of the MVI-negative group (HR = 2.39, 95% CI = 2.02-2.84, I = 22.8%; P < 0.001). Twelve studies were included in the meta-analysis of DFS, and MVI showed a worse prognosis (HR = 1.79, 95% CI = 1.59-2.02, I = 25.3%; P < 0.001). Subgroup analysis demonstrated that MVI still showed a negative effect on the long-term OS and DFS of patients with solitary small HCC measuring up to 2 cm, 3 cm, or 5 cm.

CONCLUSION

Microvascular invasion was a risk factor for poorer prognosis for solitary small hepatocellular carcinoma.

摘要

背景

微小血管侵犯(MVI)对单发小肝癌患者术后长期预后的影响仍存在争议。我们比较了 MVI 阳性和 MVI 阴性单发小肝癌患者的长期结局。

方法

系统检索 PubMed、EMBASE、Cochrane 图书馆、VIP、万方和中国生物医学文献数据库,检索时间从建库至 2018 年 11 月 1 日,比较 MVI 阳性和 MVI 阴性单发小肝癌患者的长期结局。由两位作者独立提取研究结局,包括总生存(OS)和无病生存(DFS)。

结果

纳入 14 项研究共 3033 例患者。对所有 14 项研究进行的荟萃分析表明,MVI 阳性组的 OS 显著差于 MVI 阴性组(HR=2.39,95%CI=2.02-2.84,I²=22.8%;P<0.001)。12 项研究纳入 DFS 的荟萃分析,MVI 显示预后较差(HR=1.79,95%CI=1.59-2.02,I²=25.3%;P<0.001)。亚组分析表明,MVI 对最大径达 2 cm、3 cm 或 5 cm 的单发小 HCC 患者的长期 OS 和 DFS 仍有负面影响。

结论

MVI 是单发小肝癌患者预后不良的危险因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验